Αρχειοθήκη ιστολογίου

Τρίτη 25 Ιουλίου 2017

Quality of life with biweekly docetaxel and capecitabine in advanced gastro-oesophageal cancer

ConclusionsBiweekly docetaxel with capecitabine is a feasible treatment in AGC, delivered on an outpatient basis, with no need for central venous access device. No deterioration of global health status was reported. In addition, pain and eating difficulties were alleviated during study treatment. This trial is registered atClinicalTrials.gov, number NCT00669370. (Source: Supportive Care in Cancer)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2vGhQx1
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,

Αναζήτηση αυτού του ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader